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Objectives: Body fatness is widely assumed to be regulated by a lipostatic set-point system, which has evolved in response to trade-offs in the
risks of mortality. Increasing fatness makes the risk of starvation lower but increases the risk of predation. Yet other models are available. The aim
of this work is to evaluate using mathematical modeling whether set-point systems are more likely to evolve than the alternatives.
Methods: I modeled the trade-off in mortality risks using a simple mathematical model, which generates an optimum level of fatness that is
presumed to be the driver for the evolution of a set-point. I then mimicked the likely errors in this optimum level, that derive from the variation in
the component parameters of the mortality curves using Markov Chain Monte Carlo (MCMC) simulation by Bayesian inference Using Gibbs
Sampling (BUGS).
Results: The error propagation generated by the simulations showed that even very small errors in the model parameters were magniﬁed
enormously in the location of the optimum fatness level. If the model parameters had coefﬁcients of variation of just 1% then the coefﬁcient of
variation in the optimum level of fatness was between 20 and 90%. In that situation, a set-point centered at the mathematical optimum from the
component curves would be at the correct level of fatness that minimizes mortality, and hence maximizes ﬁtness, on less than 8% of occasions.
Conclusions: Set-point regulation of body fatness is hence highly unlikely to evolve where there is any realistic level of variation in the pa-
rameters that deﬁne mortality risks. Using further MCMC modeling, I show that a dual-intervention point system is more likely to evolve. This
mathematical simulation work has important implications for how we interpret molecular work concerning regulation of adiposity.
 2017 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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It is widely assumed that body fatness is regulated by a lipostatic
regulatory system, as originally proposed by Kennedy [1]. By this
model a signal from the body reﬂecting the level of stored fat is
compared to a set-point in the brain, and deviations of the body fat
from the set-point result in compensatory responses in both energy
intake and expenditure [2e8]. The discovery of leptin [9] provided a
potential molecular reality for the signal reﬂecting the level of stored
fat. The molecular basis of the lipostatic set-point to which it is hy-
pothetically compared, however, has never been discovered. Set-point
models are not the only possible theoretical way in which body fatness
can be regulated, and various other models are available: including
settling point and dual intervention point models [10]. Moreover,
mathematical models of body fatness changes have called into
question whether animal responses to metabolic perturbations actually
behave as expected from a lipostatic set-point regulation system [11].
How the supposed set point system for body fatness evolved has been
a no less active but largely independent area of enquiry from studies
aiming to elucidate the molecular basis of the system. It has been
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of fat storage [12e14]. One of these pressures favors storage of more
fat. This is generally presumed to be the risk of starvation (but see [15]
for an argument that it is more likely to be disease risk). The starvation
argument is that under conditions of complete failure in the food supply
those individuals storing more fat will survive longer. Hence, storing
more fat reduces the risk of starvation-induced mortality. However,
there is a counteracting pressure which favors storage of less fat. This
has widely been assumed to be the risk of predation. Individuals
storing more fat may be less maneuverable and slower to evade
predators and hence storing more fat increases predation mortality
[13,14].
The tension between these opposing forces then generates an optimal
level of fat storage that minimizes mortality. This situation can be
modeled by a juxtaposition of negative and positive exponential re-
lationships between mortality and fat storage [15]. If the mortality due
to starvation (Ms) follows a negative exponential relationship
Ms¼ aebx, where x is fat storage, and mortality due to predation rises
as a positive exponential Mp¼ cegx. Then overall mortality at any given
level of fat storage Mtot ¼ Ms þ Mp and the optimal fat storage level
that minimizes mortality turn out to be analytically deﬁned asDevelopmental Biology, Chinese Academy of Sciences, Beijing, China 2Institute of
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This ﬁtness landscape is presumed to provide the selective environ-
ment in which a lipostatic set-point system can evolve, centered
around the point FA. That is, individuals regulating body fatness at
levels that do not coincide with the optimal level FA would suffer
greater mortality; hence, the genes deﬁning these deviant levels of
fatness regulation would be purged from the population. What would
then evolve is a lipostatic set-point regulating fatness at FA. It is my
contention here that such an evolutionary scenario is untenable and
that such set-point regulatory systems for body fatness are unlikely to
evolve (at least by this proposed mechanism).
The problemwith suchmathematical models is that they assume that the
curves deﬁning the risks of mortality are stable in space and time. That is,
the constants deﬁning the mortality curves (a, b, c and g) are truly con-
stant. This is extremely unlikely. The curve relating level of fatness to
mortality risk from predation, for example, will likely depend on the local
population of predators and the populations and sizes of other potential
prey. Such variationmaymake the position of the optimal fatness unstable
and hence make it difﬁcult for a lipostatic set-point system to evolve. The
key question is how much this likely variation in these parameters would
affect the value of FA. If, for example, changing the parameters up or down
by 5% has only minimal impacts on FA then the optimal solution will be
robust to the parameter estimates and a lipostatic set-point system could
still evolve. However, if FA turns out to be highly variable dependent on the
component parameter variation then this would make evolution of a
lipostatic set-point system unlikely.
2. METHODS
To investigate this question, I used Markov Chain Monte Carlo (MCMC)
simulation by Bayesian inference using Gibbs Sampling (BUGS) (using
the winBUGS software; [16]). I used the mortality trade-off model from
[15], brieﬂy outlined above, as the basis of the simulation. I selected
the values of the model parameters a, b, c, g so as to generate an
optimal body fatness (FA) of 5 units. I will refer to this from now on as
5 g as if we were modeling fat storage in a typical small mammal, but
the units are arbitrary and the model can be applied to any size of
animal. If you are more familiar with human fat storage then you may
prefer to think about the units as kg rather than grams. I then selected
six combinations of the four parameters that reﬂected different po-
tential mortality landscapes. These combinations are detailed in
Table 1, and the mortality patterns they generate are illustrated inTable 1 e Six different scenarios that were used to model evolution of set-
points. The scenarios are labeled A to F and are ordered by the increasing
sensitivity of mortality to changes in body fatness. Sensitivity is expressed
as the fold change in mortality due to starvation (Ms) and predation (Mp) that
accompanies a 10 fold change in the level of stored fat. The model involves
contrasting positive and negative exponentials and generates an optimal
fatness (FA). Parameters of the model (a, b, c, g) for each scenario are
shown.
Scenario A B C D E F
Sensitivity to
Ms 1.9 6.04 9.48 14.9 23.3 90.0
Mp 2.7 7.99 5.03 6.0 11.1 36.6
Mean 2.3 7.02 7.26 10.4 17.2 63.3
Parameters
a 0.53 1.0 1.0 1.0 1.5 2.5
b 0.07 0.2 0.25 0.3 0.35 0.5
c 0.123 0.1 0.16 0.123 0.087 0.035
g 0.117 0.231 0.18 0.2 0.27 0.4
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lating dependence of the mortality curves on body fatness. This is
reﬂected in the fold change in mortality risk from both sources as
fatness increases from 1 to 10 g (Table 1). Hence, in scenario A, the
least sensitive situation, this 10-fold increase in fatness increases
mortality due to predation by a factor of 2.7 but decreases the mortality
from starvation by a factor of 1.9. In contrast, for scenario F, the most
sensitive situation, the 10-fold increase in fatness from 1 to 10 g
resulted in a 36-fold increase in mortality due to predation and a 90-
fold reduction in mortality due to starvation.
I then assumed that variation in the four parameters followed a normal
distribution, with the means deﬁned as in Table 1 and that the standard
deviation of each distribution was deﬁned by a given coefﬁcient of
variation. The winBUGS model speciﬁcation text is available on
request. The six levels of the coefﬁcients of variation studied included
0.0001%, 0.001%, 0.01%, 0.1%, 1%, and 2%. I applied these equally
to all 4 parameters. That is, I didn’t model the situation where the
coefﬁcients of variation themselves varied between parameters. The
program was allowed to generate initial values based on the distri-
butions. In each condition, I ran 10,000 iterations of the program,
drawing random samples from the respective parameter distributions.
These were then combined in Eq. (1) to generate a sample of the
output variable FA. This resulted in 36 separate output distributions (6
scenarios multiplied by 6 different levels of parameter variation). The
output distributions of FA were then characterized by their means and
standard deviations.
In a second set of simulations, I used the same scenarios to generate
the proﬁle of mortality (Mtot) at different levels of fatness. For this
model, the mortality was simulated by drawing random samples from
the same distributions of the four parameters that deﬁne the mortality
curves, but this time instead of calculating FA the program calculated
total mortality (Mtot) as a result of both predation and starvation. I set
the CV of the deﬁning parameters at 1%, and allowed the program to
generate initial values from the starting distributions. The model was
then iterated for 10,000 samples at each of 31 values of body fatness
between 2 and 8 g (at 0.2 g intervals) for all 6 mortality scenarios. The
mean and Monte Carlo standard error for mortality at each fat level
were recorded.
3. RESULTS
As expected, given the assumed normal distributions for the compo-
nent parameter values, the resultant distribution of FA was also roughly
normal. I therefore characterized the distributions based on their co-
efﬁcients of variation and plotted these against the modeled coefﬁcient
of variation in the component parameters (Figure 2). This showed that
when the component parameters had only very low levels of variation
(CV¼ 0.0001 and 0.001%), the coefﬁcient of variation in the output FA
was between 0.16 and 2.0% depending on the mortality conse-
quences of the fat storage. Hence, there was a dramatic impact of even
minute levels of variation in the components on the position of the
optimum fatness. When the variation in the components was higher
(1%), the coefﬁcient of variation in the optimum FA varied between 20
and 90%. The gradients of exponential ﬁts to these relationships all
had exponents around 1.2. The intercepts (equal to the coefﬁcients at
component variances of 1%) were strongly linked to the average of the
mortality impacts of the initial relationships (Figure 3). In other words,
when the scenario was strongly sensitive to mortality effects the op-
timum was less variable. Nevertheless, even when the average mor-
tality effect was 60-fold (Scenario F), 1% coefﬁcients of variation in the
4 component parameters led to a 20% coefﬁcient of variation in FA.an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1: Patterns of change in total mortality (solid line) and component mortalities due to starvation (Ms) and predation (Mp) (dotted lines) in relation to body fatness. Six different
scenarios are modeled in which the dependence of mortality on fatness is progressively greater from A to F. Parameters of the equations under different scenarios are in Table 1. FA
is the optimum fatness that minimizes mortality and is solved analytically for the different functions. In all these scenarios the model parameters were selected so that FA ¼ 5.
MOLECULAR METABOLISM 7 (2018) 147e154  2017 Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 2: Variation in the optimum fatness FA (Coefﬁcient of variation %) in relation to the logged variation in the component parameters of the equation also expressed as
coefﬁcients of variation of the parameters a, b, c, g. These six plots directly refer to the six different scenarios shown in Figure 1. Fitted exponential equations are shown with the r2.
The CV of FA was derived from Markov Chain Monte Carlo simulation using the winBUGS software.
Original Article
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Figure 3: Variation in the optimum fatness FA (Coefﬁcient of variation %) when the
component parameters of the equation from which FA is calculated all vary with CV’s of
1%, plotted against the mortality sensitivity of the given scenario. Mortality sensitivity is
the fold change impact on both predation and starvation mortality resulting from a
change in fatness from 1 g to 10 g.To model the consequences of this variation in the optimum body
fatness for the evolution of set points, I considered the following sit-
uation. Imagine an animal has a set point system which is centered on
a value of 5 g (the mathematical optimal solution for the models
deﬁned without error). Assume this value has a tolerance of 0.1 g. That
is, the animal’s physiological system cannot distinguish values within
the range from 4.9 to 5.1 g (4% of the mean). This sort of percentage
variation is typical for other set-point systems that we are aware of
such as the regulation of body temperature or blood glucose levels. If
the optimum fatness FA falls within this range, then the animal is
regulating fatness at the optimum level within the limits of its own
physiology. Given this lipostatic set-point system, what percentage of
the optimum fatness values fall within this range under each scenario?
I calculated this using z-scores of the resultant MCMC derived distri-
butions of FA (Table 2). Hence, for example, with Model 2, in the sit-
uation in which the component parameters have a CV of 0.0001%, the
distribution of FA has a mean of 5 and sd of 0.013 g. Therefore, the
described lipostat with a range of 4.9e5.1 g would include values up
to 7.7 standard deviations from the mean, and hence the lipostatic set-
point system effectively always includes the optimum fatness value
(p > 0.9999). In contrast, in the same scenario but with the compo-
nent parameters, at a CV of 1%, the resultant sd was 1.525 g; hence, a
lipostatic set point system as described would only cover 0.065
standard deviations each side of the mean, or 5.2% of the optimum
fatness values. These data show that whatever the mortality sensitivity
scenario, if the component variables had CVs of only 1%, the lipostatic
set point system with 4% tolerance would cover only between 1.6 and
7.8% of the optimal fatness values. For a lipostatic set point system to
evolve, there would need to be less than 0.01% variation in the pa-
rameters deﬁning the model.
Figure 4 shows the total mortality pattern (mean values with MC error)
at intervals of 0.2 g in fatness between 2 and 8 g for scenario B, which
was derived from the second set of modeling. The plot shows a curve
with a ﬂat bottom; as fatness increases, the reduction in mortality risk
due to starvation is offset almost exactly by increases in mortality due
to predation. The grey data points deﬁne the values where the mortality
differed by less than 1% from that at the lowest point. The range thatMOLECULAR METABOLISM 7 (2018) 147e154  2017 Published by Elsevier GmbH. This is an open access
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lowest value was from 4 to 5.4 g. This range depends on the mortality
impact in the scenario. For scenario A, in which the mortality impact
was low, the range was 2.8e6.2 g. For mortality scenario F, with the
highest mortality sensitivity, the range was 4.6e5.2 g.
4. DISCUSSION
Given the reality of what these mortality curves represent (effects of
fatness on the risk of mortality from starvation and predation), it seems
highly unlikely that the deﬁning parameters for the curves would have
a variation (CV) lower than 1%; it is likely, however that they would be
considerably higher. The simulations above show that in this situation
(CV ¼ 1% in all four component parameters), if an animal had a
lipostatic set-point system that regulated fatness with a tolerance of
4% (i.e. 5 g plus or minus 0.1 g), it would only be regulating at the level
of fatness that maximizes ﬁtness on 1.6e7% of occasions. That is,
over 90% of the time, the lipostatic system would be regulating at a
set-point that was sub-optimal in terms of maximizing ﬁtness. A
system generating the wrong ﬁtness solution more than 90% of the
time is unlikely to evolve by the process of natural selection. Set point
regulation of body fatness, therefore, is unlikely to evolve, at least if the
underlying driver of the system is the contrasting mortality patterns in
relation to stored fat due to starvation and predation, as is generally
assumed.
One might argue that the result is an artifact of the nature of the curves
(a negative and positive exponential) that were selected to represent
the contrasting mortality effects. There are limited alternative options,
however, for these relationships. If the curves are made linear rather
than exponential, the solution is that when the gradient for the star-
vation effect exceeds that of the predation effect, the animal should
always store as much fat as possible. Conversely, when the gradient of
the predation effect exceeds the gradient of the starvation effect, the
animal should store no fat at all. When the gradients are equal, the
mortality is independent of fat storage. Hence, with linear relationships,
there is no optimum fat level which minimizes mortality to result in
selection for a lipostatic set-point. If the curves are made convex rather
than concave, then the mortality reaches a maximum at intermediate
levels of fatness rather than a minimum. Again, this would not result in
selection for a lipostatic set-point that minimizes mortality. So, the
most credible formulation that leads to a minimum mortality potentially
capable of generating a body fatness set point is to combine a negative
and a positive exponential.
If the modeling suggests that a lipostatic set point system is unlikely to
evolve, then what is the most likely alternative? This question was
addressed by the second set of modeling. This simulation showed that
there is always a zone where increasing fatness leads to decreased
risk of mortality from starvation that is almost exactly balanced by
increased risk of mortality from predation (Figure 4). In this range, it
would not matter what the animals body fatness is because the
mortality implications are negligible. Natural selection would be unable
to favor a given regulation set point in this range, when other options in
the same range have equal mortality and hence ﬁtness. However,
selection would be able to distinguish the points where this zone starts
and ends: that is natural selection would be able to distinguish a
difference of 3% much more readily than a difference of less than 1%.
A more likely system to evolve then would be a system locating these
upper and lower edges of the constant mortality zone. The less sen-
sitive fatness levels are to mortality effects the wider this zone will be.
This is familiar as the ‘dual intervention point’ model [10,17e19].article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). 151
Table 2 e Calculated variation (CV%) in the optimal level of fatness (FA)
resulting from variation in the component parameters for each scenario
detailed in Table 1. The values to the left labeled ‘CV parameters’ are the
assumed CV in the component parameters of the model. Using an assumed
set-point at the analytical solution to the scenarios (FA¼ 5) with a tolerance
of 4%, the proportion of situations where the set-point system would be
regulating at the optimum level of fatness is also shown labeled as
P(correct).
Scenario A B C D E F
CV parameters ¼ 0.0001%
CV% FA 0.64 0.254 0.246 0.22 0.184 0.164
P(correct) 0.9974 0.9999 0.9999 0.9999 0.9999 0.9999
CV parameters ¼ 0.001%
CV% FA 2.05 0.806 0.76 0.68 0.518 0.568
P(correct) 0.6666 0.9864 0.9914 0.9968 0.9998 0.998
CV parameters ¼ 0.01%
CV% FA 6.51 2.54 2.40 2.16 1.86 1.64
P(correct) 0.2434 0.5646 0.5934 0.646 0.718 0.7776
CV parameters ¼ 0.1%
CV% FA 20.11 8.16 7.69 6.88 5.94 5.33
P(correct) 0.0796 0.1934 0.2052 0.2282 0.2598 0.293
CV parameters ¼ 1.0%
CV% FA 94.92 30.50 27.38 24.84 21.88 21.22
P(correct) 0.016 0.0518 0.058 0.0638 0.0718 0.076
CV parameters ¼ 2.0%
CV% FA 45.50 47.12 40.32 33.02 31.10
P(correct) 0.034 0.032 0.0398 0.0478 0.044
Original ArticleA different critique might be that the initial choice of tolerance for
fatness in the lipostatic set-point model at 4% was too narrow. As
noted in the methods, this stringency was chosen on the basis of the
level of tolerance observed in other known set-point systems e such
as body temperature and blood glucose levels. If we were to relax thisFigure 4: Total mortality estimates (Mtot) derived from Markov Chain Monte Carlo simulatio
drawing values of the ﬁxed parameters in the equation for Mtot from simulated distribution
dimensions of the points. The mortality shows a curve with a ﬂat bottom (grey points) where
This deﬁnes a zone where mortality is independent to fatness.
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5  1.0 g), this changes the level of variation in the mortality curves
that still produces a level of FA that is compatible with the ‘set-point’
(i.e. inside the tolerance zone). Hence, instead of the mortality curves
needing to have a variance less than 0.01%, this would be relaxed to
around 1%, particularly if the mortality impact was large (scenario F).
Nevertheless, 1% variation in the component mortality curves is still
extremely low. Moreover, a set-point with a tolerance of 20% would
not normally be regarded as a set-point at all. For example, we would
consider that something was seriously awry in the set-point regulation
of body temperature if it varied at random by 20% before any
counter-regulation occurred. In fact, because the upper and lower
limits of the tolerance zone are so far apart, a set-point with such low
tolerance actually behaves as a dual intervention point system. Hence,
while changing the set-point tolerance changes the precise outcome of
the modeling, it converges on the same ultimate conclusion that dual-
intervention point systems can more easily evolve than set-point
systems.
This mathematical simulation exercise has some important implica-
tions for our interpretation of studies into the molecular biology of the
regulation of body fatness. If the conditions for a lipostatic set-point
system to evolve almost never exist, then this may explain why the
molecular nature of the reference point of such a system has never
been found. Clearly, further searching for it may end up a ‘holy grail’
type endeavor. Much previous work has interpreted the role of leptin as
the signal from the body that signals the level of body fatness to the
supposed lipostatic set point system. If this was the case, then levels of
leptin falling below the set-point would be expected to generate
compensatory responses to increase intake and reduce expenditure.
Such actions of leptin are often observed [20]. Similarly if leptin levels
increase above the set-point compensations to reduce intake andns at various levels of body fatness. Points are the means of 10,000 iterated calculations
s. Error bars show the MC standard error, which, in some cases, was smaller than the
the mortality differs by less than 1% from the mortality observed at the ﬁtted optimum.
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elevate expenditure should also be observed. Such responses are
largely absent, which led to the notion of leptin resistance to explain
the absence of response [21,22]. However, we only expect these re-
sponses because we start from the assumption that there is a lipostatic
set-point regulation system controlling things. From an evolutionary
standpoint, a set-point system regulating fatness with leptin resistance
poses enormous challenges to understanding how that situation might
arise. We have seen here that lipostatic set-point systems are only
likely to occur where there are large impacts of fatness on mortality
(Scenario F). Hence, an animal showing leptin resistance on top of a
lipostatic system would be exposing itself to the elevated mortality
associated with body fatness above the set point for adiposity. Such
individuals would likely be purged from the population. So, it is unclear
how ‘leptin resistance’ might evolve.
Consider, in contrast, if the evolved system we study is actually a dual
intervention point system for body fatness (as suggested here), and our
observations largely concern what is happening at the lower inter-
vention point. Such a model would predict the same responses to
falling leptin. That is if leptin signaled that fatness had fallen below the
lower intervention point the individual would be predicted to show
compensatory responses to increase intake and decrease expenditure
to bring fatness back up above the intervention point. If leptin rises
above this point, however, it would signal only that fatness had risen
into the zone of indifference (Figure 4). Hence, we would predict no
response to such rising levels. And this is indeed what is observed e
an asymmetry in response [23]. I suggest this asymmetry is not a
lipostat with leptin resistance but observations around the lower
intervention point of a dual-intervention point system for body fatness.
Leptin resistance is a construct to try to explain data that do not ﬁt the
lipostatic set point model. A more likely scenario suggested here is that
lipostatic set point system doesn’t exist in the ﬁrst place.
If we assume that a dual intervention point system is a more likely
system to evolve, as indicated here, then a major outstanding question
is what happens at the upper intervention point? Is fatness at this
position also indicated by leptin? Such a role has been recently
questioned [24e26]. If it does not, identifying what does, and the
molecular nature of the upper intervention point, should be key future
aims. One might argue that an upper intervention point is superﬂuous
and searching for the nature of this upper intervention point is no
different than searching for the ‘adiposity set-point’. Why can the
system not just be an asymmetric set point that strongly regulates on
the downside, but only weakly on the upside? The ﬁrst objection to this
interpretation is that given our current ideas about factors inﬂuencing
mortality in relation to fatness, it is entirely unclear how such a system
could evolve. The second problem is that this model ignores the wealth
of data indicating mortality impacts of elevated fatness due to pre-
dation which was likely a major force during our evolutionary history
[15,19], which would drive evolution of an upper-regulatory point.
Finally, it ignores the evidence that many people, despite living in an
‘obesogenic environment,’ do curb their increase in adiposity, pointing
to a regulatory upper boundary that is variable between individuals. I
have elaborated elsewhere where such individual variability might
emerge from [27].
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